M. Wahl, Dental surgery in anticoagnlated patients Arch Intem Med, pp.1610-1616, 1998.

A. Pclissier and S. Alantar, Antivitamins K. Mode ofaction, indications, principlcs of treatntent, l'Ole ofthe dentist, Actual üdontostomatol (Paris), pp.127-167, 1990.

. Sfmbcb, Reconnnandations pour la prise en charge des patients sous traitement anti-vitcnnines K en chirurgie bucco-dentaire, pp.187-212, 2006.

. Schofield and . Hentorrhagic, \'\l'eel clover dise ose in caille, Can Vet J, vol.3, pp.74-79, 1922.

. Sehoficld, Daniaged sweet elever: the cause ofa new disease in caille simulating hemorrhagic septiceinia and black leg, JA VMA, vol.64, pp.553-72, 1924.

. Roderiek, Problems in the coagulaiion ofthe blood: "sweet clover diseuse ofcattle

R. Muel\er and S. Sehcidt, History ofdrugsfor thrombotic diseuse. Discovery, development, and directionsfor thefuture. Circulation, pp.432-481, 1994.

K. Link, The discovery ofdicumarol and ils sequels. Circulation 07. 12. Quick. A study ofthe coagulation defect in haemophilia and in jaundice, Am J Med Sci, vol.19, issue.190, pp.97-197, 1935.

H. Bult, B. Allen, and J. Bol\mann, A preparationfrom spoiles swette clover which prolongs coagulation and prothrombin lime ofthe blood: preliminary report ofexperimental and clinicat studies, Proc Staff Meet, Mayo Clin, vol.16, pp.388-95

J. Bingham and F. Meyer-00-le, STUDIES ON THE HEMORRHAGIC AGENT 3,3'-METHYLENEBIS (4-HYDROXYCOUMARIN)., The American Journal of the Medical Sciences, vol.202, issue.4, pp.563-78, 1941.
DOI : 10.1097/00000441-194110000-00009

I. Wright, C. Marple, and D. Beek, Report ofthe Committee for the Evaluation of Anticoagulants in the Treatment ofCoronary Thrombosis with Myocardial Irfarction; a progress report on the statistical analysis ofthefirst 800 cases studied by this committee, Am Heart, vol.136, pp.801-816, 1948.

I. Wright, Experiences with dicumarol (3,3???methylene-bis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction Preliminary report, American Heart Journal, vol.32, issue.1, pp.20-31, 1946.
DOI : 10.1016/0002-8703(46)90223-2

B. Pollock, Clinical experience with warfarin (coumadin) sodium. a ne\l' anticoagulant. J Am Med Assac, pp.1094-1101, 1955.

D. Whitlon, J. Sadowski, and S. Nv, Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition, Biochemistry, vol.17, issue.8, pp.1371-1378, 1978.
DOI : 10.1021/bi00601a003

R. Bell, lvJelaholislII ofvitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle. Fcd Pmc, pp.2599-604, 1978.

Y. Gruel and A. Maakaroun, Accidents caused by anticoagulants. Rev Prat, pp.1929-1964, 2002.

I. Elalamy, . Smm, and J. P. Tillcment, Phannacological characteristics oforal vitamin K antagonists, Sem Hôp Paris, vol.71, pp.401-409, 1995.

P. Mismctti, H. Decousus, and . Anticoagulants, Antivitamins K: principles and rules ofuse, posology]. Rcv Prat, 25. GEHT. Les recommandations 2000 : Utilisations des Antivitamine Ken pratique médicale courante, pp.1014-1021, 1995.

T. Andrews, P. Inv, D. Doeppenschmidt, J. Foster, M. Lueca et al., Complications ofwarfarin therapy monitored by the International Nortnalized Ratio versus 1he prothrom bin 1ime ratio. Clin Cardia 1. 1995 Fcb Hereditary Transmission ofExceptional Resistance la Coumarin Anticoagulant Drugs. The First Reported Kindred, N Engl J Med, vol.18271, pp.80-82, 1964.

A. Fiche-de-transparence, AFSSAPS. Mise au point SUI' le hon usage des médicaments antivitamine K Principales informations concernant les indications el la surveillance dutraitement pour les professionnels de santé, 2000.

P. Pouyanne, F. Haramburu, J. Imbs, and B. Begaud, Admissions la hospital caused by adverse drug reactions: cross sectional incidence study
DOI : 10.1136/bmj.320.7241.1036

URL : http://www.bmj.com/content/bmj/320/7241/1036.full.pdf

P. Michel and . Cc, Elude Nationale sur les Evènements ln désira hies graves liés aux Soins: élude ENEIS Fascicule Etudes et Résultats n0398 34. CRPV. Effets Indésirables des Medicaments: Incidence et Risque SUI' les hospitalisations liées cl un effe: indésirable nuulicamentenx. . Coordination CRPV de Bordeaux. 2007. 35. HAS. Prise en charge des surdosages en antivitantines K, des simations cl risque hémorragiq lie el des accidents héJJlorragiques chez les pal jents traités par an! il, p.36, 2005.

C. Madrid, Deniai extractions in patients taking anricoagnlants: is alteration of/he anticoagulant regime necessary"], Rev Med Suisse, vol.1, 1418.

B. Jung, Deniai extractions on anticoagulants: iniproving pructice with a multidisciplinary approach]. Arch Mal Coeur Vaiss, pp.857-865, 2005.

R. Mulligan and K. Weitzel, Pretreannent management ofthe patientreceiving amicoagnlant drugs Tinker JH, T'arhan S. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observa/ions in 180 operations, J Am Dent Assoc. JAMA Feb, vol.117239, issue.20, pp.479-83738, 1978.

G. Russo, L. Corso, A. Biasiolo, M. Bercngo, and V. Pengo, Simple and safe method 10

S. Cosgriff, Chronic onticoagulant therapy in recurrent embolism ofcardiac origin

M. Akbarian, G. Austen, P. Yurchak, and J. Scanncll, Thromboembolic complications ofpros/he/ic cardiac valves. Circulation, pp.826-857, 1968.

. Marshall, Rebound Phenomena afier Anticoagulant Therapy in Cerebrovascnlor Disa/se, Circulation, vol.128, pp.329-361, 1963.

H. Ogiuchi, T. Ando, M. Tanaka, T. Kuwasawa, Y. Sangu et al., Clinical reports on den/al extractionfront patients undergoing oral anticoagulanttherapy. Bull Tokyo Dent Coll, pp.205-217, 1985.

L. Evans, M. , A. J. Gibbons, G. Pricc, H. Snooks et al., Can warfarin be continued during dental extraction? Results of a randomized controlled trial, British Journal of Oral and Maxillofacial Surgery, vol.40, issue.3, pp.248-52, 2002.
DOI : 10.1054/bjom.2001.0773

F. Herion, D. Il, P. Boxho, and E. Rompcn, Anti-vitamins K and oral surgery: the end oftheirprohibiüon"], Rev Med Liege, vol.57, pp.330-333, 2002.

Y. Manor, U. Martinowitz, and S. Taieher, Den/al extractions in patients maintained on oral anticoagulant therapy: comparison 0/1NR value with occurrence of postoperative bleeding, Rev Stomatol Chir Maxillofac Int J Oral Maxillofac Surg Dee, vol.10830, pp.189-92518, 2001.

. Devani-l-', K. Lavcry, C. Howell, and . Den, ions in patients on warfarin: is alteration ofanticoagulant regime ncccssary?107- Il. 52. Cannon PD, Dharrnar VT. A/inor oral surgical procedures in patients on oral an/icoagulan/s--a controlled s/lIC61 Rev Stomatol Chir Maxillofac, 53. Gareia-Darennes F, Darennes J, Freidel M, Breton p. [Protocolfor adapting treatment with vitamin K antagonists before den, pp.115-869, 1998.

S. Sindet-pedersen, G. Ramstrom, S. Bcrnvil, and M. Blomback, Hemostatic Effect of Tranexamic Acid Mouthwash in Anticoagulant-Treated Patients Undergoing Oral Surgery, New England Journal of Medicine, vol.320, issue.13, pp.840-843, 1989.
DOI : 10.1056/NEJM198903303201305

G. Borca, L. Montebugnoli, . Capuzzi-l-', and C. Magelli, Tranexamic acid as a mouthwash in anticoagulant-trecned patients undergoing oral surgery. An alternative niethod /0 discontinuing anticoagulant therapy, pp.29-31, 1993.

G. Ramstrom, S. Sindct-pedcrscn, G. Hall, M. Blomback, and U. Alander, Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants, Journal of Oral and Maxillofacial Surgery, vol.51, issue.11, pp.1211-1217, 1993.
DOI : 10.1016/S0278-2391(10)80291-5

L. Bodner, . Weinstein, . Lm, A. Baumgarten, W. Halfpenny et al., EffiC(}é)! offibrin sealant in patients on varions levels oforal anticoagulant undergoing oralsurgery Oral Surg Oral Med Oral Pathol Oral Radiol Endod Coniparison of2 hemostatic agentsfor the l'l'even/ion ofpostextraction hemorrhage in patients on anticoagulants Hemostatic effec/ ofn-butyl-ê-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery, J Oral Maxillofac Surg, vol.8692, issue.60, pp.421-4257, 1998.

G. Carter, A. Goss, J. Lloyd, R. Toeehetti, A. Dunn et al., Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study, Journal of Oral and Maxillofacial Surgery, vol.61, issue.12, pp.1432-590, 2003.
DOI : 10.1016/j.joms.2003.01.001

D. Alagille, A. Lambert, P. Laudenbaeh, and M. Poulain, Utilization ofepsilon-atninocaproic acid in hemostasis in slolllaiology in heniophiliacs, Rev Stomatol Chir Maxillofac, vol.66, pp.197-203, 1965.

P. Schcffer and P. Laudenbaeh, Dental extractions in cardiac cases under anticoagulant therapy, Coeur Mec! Interne, vol.7, pp.451-454, 1968.

F. Henry, Iemostasis in 100117 extraction with a resorcin-fonnol gel poste] Rev Stomatol Chir MaxillofacVahl MJ. Myths ofdentalsurgery in patients receiving anticoagulant therapy, J Am Dent Assoc, vol.77131, issue.66, pp.307-977, 1976.

J. Little, . Fd, C. Miller, and N. Rhodus, Bleeding disorders In: dental management of the tnedically compromised patient. 5th ec! St Louis: Mosby-Year Book, pp.466-94, 1997.

S. Cohen and . Gm, Anticoagulants therapy Internat medicine for dentistry, p.374, 1990.

M. Greenberg, M. Miller, and M. Lynch, Partial Thromboplastin Time as a Predictor of Blood Loss in Oral Surgery Patients Receiving Coumarin Anticoagulants, The Journal of the American Dental Association, vol.84, issue.3, pp.583-590, 1972.
DOI : 10.14219/jada.archive.1972.0087

B. Bailey and A. Fordyce, Complications of dental extractions in patients receiving warfarin anticoagulant therapy. A controlled clinical trial, British Dental Journal, vol.155, issue.9, pp.308-318, 1983.
DOI : 10.1038/sj.bdj.4805221

A. Fcki and C. Revue-infos, Association Dentaire Française, p.6, 2006.

H. Levcsque and J. Peron, [Platelet aggregalion inhibitors and vitantin K antagonists in stoinatology and maxillo-facial surgery], Rev Stornatol Chir Maxillofac Extraction dentaire chez les patients sous antithrombotique oral, La Revue Prescrire, vol.104281, issue.74, pp.80-90294, 2003.

. Gangloff, Prise en charge despatients sous agents antiplaquettaires el antivltamines K, Réalités Cliniques, vol.19, pp.69-78, 2008.

A. Eighazoini, Les malades sous antivitaniines Ken odontostomatologie

J. Hirsh, J. Dalcn, D. Deykin, L. Bussey, and H. , Oral anticoagulants. Meclutnism ofaction, clinicat effectiveness, and optimal therapeutic range, Chest, pp.231-277, 1995.

J. Hirsh, J. Dalcn, D. Anderson, L. Bussey, H. et al., Oral anticoagulants: niechanism ofaction, clinicat effectiveness. and optimal therapeutic range. Chcst, pp.445-69, 1998.

C. Kearon and H. J. , Management ofanticoagulation bcfore and after elective surgery

J. Souto, A. Oliver, J. Zuazu-jausoro, A. Vives, and J. Fontcuberta, Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: A prospective randomized study, Journal of Oral and Maxillofacial Surgery, vol.54, issue.1, pp.27-32, 1996.
DOI : 10.1016/S0278-2391(96)90297-9

D. Matchar, D. Manor, Y. Martinowitz, U. Taicher, S. Hashomer et al., Managing oral anticoagulant therapy Dental extractions in patients maintaincd on continued oral anticoagulant: comparison oflocal hemostutic modalities. Oral Surg Oral Mcd Oral Pathol Oral Radiol Endod, 22S-3 8S. 82. Blinder D, pp.137-177, 1999.

V. Barrcro, M. Knezevic, M. , T. Martin, M. et al., Oral surgery in patients undergoing oral anticoagulant therapy. Mcd Oral, pp.63-69, 2002.

J. Ansell, The perioperative management ofantithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest, 2008.

G. Palareti, A guide 10 oral anticoagulant therapy. ltalian Federation of Anticoagulation Clinics, Haemostasis, vol.28, issue.1, pp.1-46, 1998.

J. Hirsh and R. Raschke, Heparin and Low-Molecular-Weight Heparin, Chest, vol.126, issue.3, pp.188-203, 2004.
DOI : 10.1378/chest.126.3_suppl.188S

J. Lcong and C. Rr, The use of1011' molecular weight heparins in outpatient oral surservfor patients receiving anticoagulant oral therapy, J Am Dent Assoc, vol.133, pp.1083-1090, 2002.

. Aldous, . La, and C. Oison, Managing patients on warfarin therapy: a case report, Spec Care Dentist, pp.109-121, 2001.
DOI : 10.1111/j.1754-4505.2001.tb00236.x

M. Head, T. Leclerc, and J. , Dental extract ions in pat ients on on oral anticoagulant: a surrey ofpractices in North America, J Oral Maxillofac Surg, vol.26, pp.2463-71, 1998.

J. Ritchie, M. Cheitlin, K. Eagle, T. Ganlncr, A. Garson et al., A CC/AHA Guidelinesfor the Management ofPatients wn» Valvular Heart Disease. Executive Summary. A report ofthe American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management ofPatients With Valvular Heart Disease) J Heart Valve Dis, pp.672-707, 1998.

M. Wahl and J. Howell, Altering anticoagulation therapy: a survey ofphysicians, J Am Dent Assoc, vol.27, pp.625-631, 1996.

M. Lassalle, Extraction dentaire sous antivitantine K: Est-ce possible?, 2005.

P. Leger, C. Bus, J. Boneu, B. Boeealon, and H. , Les cliniques d'anticoagulants. Sang Thromb Vaiss, pp.288-90, 2003.

P. De-moerloose and B. Boneu, Traitement anticoagulant el éducation du patient: une nécessité, Sang Thromb Vaiss, vol.11, pp.647-52, 1999.

. France, organisation, promises and difficulties. 17'10 international congress on thrombosis, Pathophysiol Haemost Thromb, vol.32, p.10, 2002.